149354-13-2

Basic information

• Product Name: 1-ACETYL-4-(4-HYDROXYPHENYL)PIPERIDINEKETOCONAZOLE
• Synonyms: 1-ACETYL-4-(4-HYDROXYPHENYL)PIPERIDINEKETOCONAZOLE;1-[4-(4-Hydroxyphenyl)piperidin-1-yl]ethan-1-one
• CAS NO: 149354-13-2
• Molecular Formula: C₁₃H₁₇NO₂
• Molecular Weight: 219.282
• Mol File: 149354-13-2.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 415.3±45.0 °C(Predicted)
• Appearance: /
• Density: 1.145±0.06 g/cm3(Predicted)
• PKA: 10.15±0.30(Predicted)
• CAS DataBase Reference: 1-ACETYL-4-(4-HYDROXYPHENYL)PIPERIDINEKETOCONAZOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-ACETYL-4-(4-HYDROXYPHENYL)PIPERIDINEKETOCONAZOLE(149354-13-2)
• EPA Substance Registry System: 1-ACETYL-4-(4-HYDROXYPHENYL)PIPERIDINEKETOCONAZOLE(149354-13-2)

Safety Data

• Hazardous Substances Data: 149354-13-2(Hazardous Substances Data)

Usage

Purpose

Used as an antifungal medication in pharmaceuticals

Class

Belongs to the azole class of antifungal drugs

Common Uses

Treats fungal infections of the skin, hair, and nails

Mechanism of Action

Inhibits the synthesis of ergosterol, a component of fungal cell membranes

Effect on Fungal Cells

Disrupts growth and replication of fungal cells

Additional Studies

Potential application in the treatment of certain types of cancer

Cancer Treatment Mechanism

Inhibits the growth of cancer cells

Precautions

Potential side effects and drug interactions; should be used under the guidance of a healthcare professional

Upstream product

• 149354-15-4 4-(1-acetylpiperidin-4-yl)phenyl acetate 
• 62614-84-0 4-(4-hydroxyphenyl)-1,2,3,6-tetrahydropiperidine 

Relevant articles and documents

SSAO INHIBITORS AND USES THEREOF

Described herein are compounds that are semicarbazide-sensitive amine oxidase (SSAO) inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in treating or preventing a liver disease or condition.

2-pyrrolidinones, pharmaceutical compositions containing these compounds and processes for preparing them

The invention relates to cyclic imino derivatives of general formula wherein A, B, E, X2 to X5 and Y are defined as in claim 1, the stereoisomers, tautomers, mixtures and salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, which have valuable pharmacological properties, preferably aggregation-inhibiting effects, pharmaceutical compositions which contain these compounds and processes for preparing them.